Unconfigured Ad
Collapse
X
-
Hi,
Is it possible to get vcf output using somatic mutation calling? If yes what should be the option in the command line?
Leave a comment:
-
Hi Dan,
thanks very much for the announcement, and the new format seems to be working great!
Gordon
Leave a comment:
-
Hello,
We've just released VarScan v2.3.1 with better VCF compatibility; it should create VCF4.1 output. If it does not, please let me know!
Yours,
Dan Koboldt
Leave a comment:
-
Hi dkoboldt,
I've just started using VarScan (v2.2.11) and so far am very happy with what it can do. I am formatting my output from mpilup2snp and mpileup2indel as VCF, but, for me at least, the output is in version 4.0 (see header information below), not 4.1 as stated above. Is there another option distinct from setting "--output-vcf 1" to set it to version 4.1?
##fileformat=VCFv4.0
##source=VarScan2
##INFO=<ID=DP,Number=1,Type=Integer,Description="Total Depth">
##FILTER=<ID=str10,Description="Less than 10% or more than 90% of variant supporting reads on one strand">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=GQ,Number=1,Type=Integer,Description="Genotype Quality">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Read Depth">
Leave a comment:
-
Hello,
The germline P-value in VarScan output is computed when a site has been classified as Germline (the same in both normal and tumor). In this situation, the read counts from normal and tumor are combined into a total number for each allele (reference and variant). This is compared via Fisher's Exact Test to the null hypothesis, a wild-type position, at which all reads should reflect the reference allele.
The VCF 4.1 output option is available with VarScan 2.2.8 and above. However, it is currently only enabled for multi-sample calling functions mpileup2snp, mpileup2indel, and mpileup2cns. We are working on making VCF output an option for somatic mutation calling for the next release.
Leave a comment:
-
Questions about VarScan
Hi all. I'm a student working to identify tumor-specific mutations.
Recently I've came up to VarScan and SomaticSniper.
There are some confusions about using VarScan, and I see that the documentation is somewhat lacking in catching up its own versions, so I ask this question here
!
I'm using VarScan.v2.2.8.jar somatic when doing my analyses.
1. When What is the "germline p-value" exactly?
1.1. I see that --somatic-p-value sets a p-value to statistically test (Fisher's exact test) whether "normal variant allele frequency of one locus" is the same as "tumor variant allele frequency of one locus".
( Many thanks about the discussion here (it really was a great help!
):
http://seqanswers.com/forums/showthr...hlight=varscan )
So for example, I thought such contingency table could be made (I drew it crudely because I could not put in spaces instead of hyphens and underscores; ugly, isn't it?):
------------Normal--Tumor
Reference___10______2
1 Variant_____2______8 --> Fisher's exact p-value calculated.
...where the counts are reads mapped to the locus.
1.2. However, how can a "germline p-value" be calculated? D. Koboldt (the developer) himself explained that this germline p-value is "the null hypothesis is that the sample is homozygous-reference; under this hypothesis, all reads should support the reference base", which I do not understand exactly. I ask for a comment about this matter.
2. Can VarScan emit output in VCF (variant call format)?
It is written that now VarScan supports output to be in VCF, as written on the main web page as "VarScan v2.2.8 released with new somatic calling features: Tumor-normal mpileup compatibility and VCF 4.1 output option." (http://varscan.sourceforge.net/index.html)
However, all I can find inside the documentation (or I'm doing something wrong) is about v2.2, not v2.2.8.
I really hope somebody could give me a warm hand.
Have a great day!!
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Genome Sequencing Reveals Large, Repeat-Rich DNA in Trapdoor Spider Named for Stephen Colbert
by SEQadmin2
Started by SEQadmin2, 10-28-2026, 09:57 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:57 AM
|
||
|
Started by SEQadmin2, 10-28-2026, 09:51 AM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:51 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
67 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
47 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
Leave a comment: